National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

Mylotarg (MY-loh-targ)

 A monoclonal antibody combined with a toxic substance that is used to treat certain types of acute myeloid leukemia in older patients and is being studied in the treatment of other types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Mylotarg is a type of antibody-drug conjugate. Also called gemtuzumab and gemtuzumab ozogamicin.



Previous Definitions:myeloproliferative disorder, myelosclerosis with myeloid metaplasia, myelosuppression, myelosuppressive therapy, Mylosar
Next Definitions:myoclonic jerk, myoinositol, myometrium, myristyl nicotinate cream, MZL

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov